Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-02-03 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
In compliance to Regulation 47 of SEBI (LODR) Regulation, 2015; We are enclosing herewith the copies of the Notice of the ensuring Board Meeting of the Company schedule to be held on Saturday, ....
Regulatory Filings
2023-02-03 English
TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Board/Management Information Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to the Corporate Relationship Department of BSE Limited. It informs about an upcoming Board Meeting scheduled for 11th February 2023 to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2022. The letter also mentions the closure of the trading window as per insider trading regulations. The document is short (2622 characters) and serves as a notice of a board meeting and intention to approve financial results, not the financial results report itself. It is an announcement related to board/management activity and regulatory compliance under SEBI regulations. Therefore, the document fits best under Board/Management Information (MANG).
2023-02-02 English
We are enclosing herewith the confirmation certificate dated 6th January 2023 received from M/s. Link Intime India Pvt. Ltd., Registrar and Share Transfer Agent (RTA) of our Company as ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, confirming securities dematerialization for the quarter ended 31st December 2022. It is addressed to the stock exchange and includes a confirmation certificate from the Registrar and Share Transfer Agent. The document is short (3771 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities dematerialization, fitting best under Regulatory Filings (RNS) as it is a regulatory announcement and certification rather than a report or detailed filing.
2023-01-14 English
Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks ....
Regulatory Filings Classification · 95% confidence The document is a submission to the stock exchange (BSE Limited) regarding the statement of defaults on payment of interest or repayment of principal amount on loans and unlisted debt securities as per SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It contains a table showing no defaults as of 31st December 2022. The document is a regulatory compliance filing related to financial indebtedness and defaults, not a full financial report or earnings release. It is short (2873 characters) and serves as a regulatory disclosure rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS).
2023-01-14 English
Closure of Trading Window for the quarter ended on 31st December 2022 Pursuant to Clause 4 of Schedule B read with Regulation 9 of Securities and Exchange Board of India (Prohibition ....
Regulatory Filings Classification · 95% confidence The document is a notice from Triochem Products Limited regarding the closure of the trading window for insiders due to the upcoming declaration of financial results for the quarter ended 31st December 2022. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations and BSE circulars. The document does not contain any financial statements or detailed financial data but is an announcement related to trading restrictions ahead of financial results disclosure. It is not the financial report itself, nor a transcript or management discussion. The document is short and serves as a regulatory compliance notice about insider trading restrictions, which fits best under Regulatory Filings (RNS).
2022-12-31 English
In compliance to Regulation 47 of SEBI (LODR) Regulation, 2015; We are enclosing herewith extract of newspaper copy of Unaudited Financial Results for the quarter and half year ended 30th ....
Regulatory Filings
2022-11-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.